Ascendiant Capital Assumes Oragenics (OGEN) at Buy
Tweet Send to a Friend
Ascendiant Capital analyst Edward Woo assumes coverage on Oragenics (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
